Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer

per Ulivi, Paola, Marisi, Giorgia, Passardi, Alessandro
Publicat a Oncotarget (2016)

Special Issue on Basic and Translational Research in Colorectal Cancer

per Ulivi, Paola, Scarpi, Emanuela, Passardi, Alessandro
Publicat a Int J Mol Sci (2019)

Molecular and Translational Research on Colorectal Cancer

per Passardi, Alessandro, Scarpi, Emanuela, Ulivi, Paola
Publicat a Int J Mol Sci (2020)

Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0

per Passardi, Alessandro, Scarpi, Emanuela, Ulivi, Paola
Publicat a Int J Mol Sci (2021)

Immune Checkpoints as a Target for Colorectal Cancer Treatment

per Passardi, Alessandro, Canale, Matteo, Valgiusti, Martina, Ulivi, Paola
Publicat a Int J Mol Sci (2017)

Discrepancies between VEGF −1154 G>A Polymorphism Analysis Performed in Peripheral Blood Samples and FFPE Tissue

per Marisi, Giorgia, Passardi, Alessandro, Calistri, Daniele, Zoli, Wainer, Amadori, Dino, Ulivi, Paola
Publicat 2014

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab

per Del Re, Marzia, Ulivi, Paola, Passardi, Alessandro, Zoli, Wainer, Danesi, Romano, Amadori, Dino
Publicat 2014

Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?

per Molinari, Chiara, Marisi, Giorgia, Passardi, Alessandro, Matteucci, Laura, De Maio, Giulia, Ulivi, Paola
Publicat a Int J Mol Sci (2018)

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

per CHIADINI, ELISA, SCARPI, EMANUELA, PASSARDI, ALESSANDRO, CALISTRI, DANIELE, VALGIUSTI, MARTINA, SARAGONI, LUCA, ZOLI, WAINER, AMADORI, DINO, ULIVI, PAOLA
Publicat a Oncol Lett (2015)

Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients

per Pirini, Francesca, Pasini, Luigi, Tedaldi, Gianluca, Scarpi, Emanuela, Marisi, Giorgia, Molinari, Chiara, Calistri, Daniele, Passardi, Alessandro, Ulivi, Paola
Publicat a Int J Mol Sci (2020)

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

per Ulivi, Paola, Canale, Matteo, Passardi, Alessandro, Marisi, Giorgia, Valgiusti, Martina, Frassineti, Giovanni Luca, Calistri, Daniele, Amadori, Dino, Scarpi, Emanuela
Publicat a Int J Mol Sci (2018)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

per Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
Publicat 2006-03-01

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

per Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
Publicat 2006

Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results

per Passardi, Alessandro, Fanini, Francesca, Turci, Livia, Foca, Flavia, Rosetti, Paola, Ruscelli, Silvia, Casadei Gardini, Andrea, Valgiusti, Martina, Dazzi, Claudio, Marangolo, Maurizio
Publicat a Oncologist (2017)

Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer

per Rapposelli, Ilario Giovanni, Casadei-Gardini, Andrea, Vivaldi, Caterina, Bartolini, Giulia, Bernardini, Laura, Passardi, Alessandro, Frassineti, Giovanni Luca, Massa, Valentina, Cucchetti, Alessandro
Publicat a Biomolecules (2021)

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer

per Molinari, Chiara, Salvi, Samanta, Foca, Flavia, Teodorani, Nazario, Saragoni, Luca, Puccetti, Maurizio, Passardi, Alessandro, Tamberi, Stefano, Avanzolini, Andrea, Lucci, Enrico, Calistri, Daniele
Publicat a Onco Targets Ther (2016)

Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival

per Gardini, Andrea Casadei, Marisi, Giorgia, Canale, Matteo, Foschi, Francesco Giuseppe, Donati, Gabriele, Ercolani, Giorgio, Valgiusti, Martina, Passardi, Alessandro, Frassineti, Giovanni Luca, Scarpi, Emanuela
Publicat a Onco Targets Ther (2018)

Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models

per Tesei, Anna, Leonetti, Carlo, Zupi, Gabriella, Scarsella, Marco, Brigliadori, Giovanni, Ulivi, Paola, Fabbri, Francesco, Arienti, Chiara, Amadori, Dino, Passardi, Alessandro, Silvestrini, Rosella, Zoli, Wainer
Publicat 2011

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

per Zoli Wainer, Zumaglini Federica, Oliverio Giovanni, Pasquini Enzo, Dazzi Claudio, Dall'Agata Monia, Cecconetto Lorenzo, Passardi Alessandro, Nanni Oriana, Milandri Carlo, Frassineti Giovanni, Amadori Dino
Publicat 2008-10-01

Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

per Passardi, Alessandro, Scarpi, Emanuela, Tamberi, Stefano, Cavanna, Luigi, Tassinari, Davide, Fontana, Annalisa, Pini, Sara, Bernardini, Ilaria, Accettura, Caterina, Ulivi, Paola, Frassineti, Giovanni Luca, Amadori, Dino
Publicat a PLoS One (2015)